To. Tange et al., IN-VITRO INTERACTION BETWEEN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REV PROTEIN AND SPLICING FACTOR ASF SF2-ASSOCIATED PROTEIN, P-32/, The Journal of biological chemistry, 271(17), 1996, pp. 10066-10072
Continuous replication of human immunodeficiency virus type 1 requires
the expression of the regulatory protein Rev, which binds to the Rev
response element (RRE) and up-regulates the cytoplasmic appearance of
singly spliced and unspliced mRNA species. It has been demonstrated th
at the murine protein YL2 interacts with Rev in vivo and modulates the
activity of Rev (Luo, Y., Yu, H., and Peterlin, B. M. (1994) J. Virol
. 68, 3850-3856). Here we show that the YL2 human homologue, the p32 p
rotein, which co-purifies with alternative splicing factor ASF/SF2, in
teracts directly with the basic domain of Rev in vitro and that the Re
v-p32 complex is resistant to high concentrations of salt or nonionic
detergent. Protein footprinting data suggest that Rev interacts specif
ically with amino acids within the 196-208 region of p32. An analysis
of the ternary complex, formed among p32, Rev, and RRE RNA, shows that
Rev can bridge the association of p32 and RRE. Furthermore, we demons
trate that exogenously added p32 specifically relieves the inhibition
of splicing in vitro exerted by the basic domain of Rev. Our data are
consistent with a model in which p32 functions as a link between Rev a
nd the cellular splicing apparatus.